Treatment of advanced gastric cancer with cetuximab plus chemotherapy followed by surgery. Report of a case

Riccardo Casadei, Daniela Rega, Carmine Pinto, Francesco Monari, Claudio Ricci, Gianluca Sciannamea, Francesco Minni

Research output: Contribution to journalArticlepeer-review

Abstract

The prognosis of patients affected by advanced gastric cancer who did not undergo non-curative resection is extremely poor. We report a case of a 26-year-old woman affected by gastric cancer with peritoneal carcinosis in whom surgical treatment was not considered. The patient was enrolled in the Italian phase II trial of cetuximab (Erbitux, Merck KGaA, Darmstadt, Germany), a monoclonal antibody, in combination with docetaxel and cisplatin chemotherapy. Restaging of the tumor showed progressive regression, so the patient underwent a total gastrectomy. The patient is alive, well and disease-free ten months after surgery. The good result achieved in this patient provides interesting prospects for chemotherapy combined with cetuximab, followed by surgery.

Original languageEnglish
Pages (from-to)811-814
Number of pages4
JournalTumori
Volume95
Issue number6
Publication statusPublished - Nov 2009

Keywords

  • Cetuximab
  • Gastrectomy
  • Gastric cancer
  • Neoadjuvant therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Treatment of advanced gastric cancer with cetuximab plus chemotherapy followed by surgery. Report of a case'. Together they form a unique fingerprint.

Cite this